Skip to main content

Table 4 Evaluating the robustness of the existing ATX assay technology

From: Nano-level assay of attention-deficit/hyperactivity disorder medicament, atomoxetine by molecular-size-based resonance rayleigh scattering strategy. Employment in content uniformity, dosage form, and plasma analysis

Parameter

± optimum value

% Recovery* ± SD

pH

3.0

100.08 ± 0.35

3.2

99.35 ± 1.28

Buffer volume (mL)

1.1

98.76 ± 1.18

1.3

99.27 ± 0.71

Dye volume (mL)

1.1

98.37 ± 1.39

1.3

101.02 ± 1.62

  1. *Mean of three replicate measurements, SD = Standard deviation
Back to article page

BMC Chemistry

ISSN: 2661-801X

Contact us